(Q29037475)

27 March 2017

0 references

1 reference

Houssam E. Mardini

1

1 reference

27 March 2017

Alla Y. Grigorian

series ordinal

2

1 reference

27 March 2017

publication date

September 2014

1 reference

Inflammatory Bowel Diseases

27 March 2017

published in

1 reference

27 March 2017

volume

20

1 reference

27 March 2017

issue

9

1 reference

27 March 2017

page(s)

1562-1567

1 reference

Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies

27 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000084

Probiotics for the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000084

Probiotics in the treatment of human inflammatory bowel diseases: update 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000084

Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000084

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000084

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000084

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000084

Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000084

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000084

Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000084

An evidence-based systematic review on medical therapies for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000084

Reasons or excuses for avoiding meta-analysis in forest plots

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000084

VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000084